udy of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis.Arthritis Rheum,1996,39:1092-1096. 12,Elliott MJ,Maini RN,Feldman M,et al.Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.Lancet,1994,344:1105-1110.
13,Soden M,Rooney M,Whelan A,et al.Immunohistological analysis of the synovial membrane:search for predictors of the clincal course in rheumatoid arthritis.Ann Rheum Dis,1991,50 673-676.
14,Firestein GS.Invasive fibroblask-like synoviocytes in rheumatoid art-hritis:passive responders or transformed aggressors?Arthritis Rheum,1996,39:1781-1790.
15,Muller-Ladner U,Kriegsmann J,Franklin BN,et al.Synovial fibroblasts of patients with rheumatoid arthritis attack to and invade normal human cartilage when engrafted into SCID mice.Am J Pathol,1996,149:1607-1615.
16,Firestein GS,Yeo M,Zvaifler NJ.Apoptosis in rheumatoid arthritis synovium?J Clin Invest,1995,96:1631-1638.
17,Beg AA,Baltimore D.An essential role for NF-κB in preventing TNFα-induced cell death.Science,1996,274:782-784.
18,Sugiyama M,Tsukazaki T,Yoneckura A.Location of apoptosis and related proteins in the synovium of patients with rheumatoid arthritis.Ann Rheum Dis,1996,55:442-449.
19,Datta SK,Kalled.CD40-CD40 ligand interaction in autoimmune disease.Arthris Rheum,1997,40:735-745.
20,Knoerzer DB,Karr RW,Schwartz BD,et al.Collagen induced arthritis in the BB rat:prevention of disease by treatment with CTLA-4-Lg.J Clin Invest,1995,96:987-993.
21,Cuss JJ,Splawski JB,Thomas R,et al.Elevated interleukin-10 levels in patients with rheumatoid arthritis.Arthritis Rheum,1995,38:96-104.
22,Joosten LAB,Lubberts E,Durez P,et al.Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis:protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.Arthritis
上一页 [1] [2] [3] [4] [5] 下一页